Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03522961Active, not recruiting
Randomised, double-blind trial (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Treatment for clinically suspected or culture-proven UTI at 28 days. Started Aug 2018; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03522961.